Immunogenicity of SARS-CoV-2 spike antigens derived from Beta & Delta variants of concern.
Akache B, Renner TM, Stuible M, Rohani N, Cepero-Donates Y, Deschatelets L, Dudani R, Harrison BA, Gervais C, Hill JJ, Hemraz UD, Lam E, Régnier S, Lenferink AEG, Durocher Y, McCluskie MJ.
Akache B, et al. Among authors: hill jj.
NPJ Vaccines. 2022 Oct 12;7(1):118. doi: 10.1038/s41541-022-00540-7.
NPJ Vaccines. 2022.
PMID: 36224247
Free PMC article.